PUXANO
About
Platform-based biotech company focusing on structure-guided antigen design and native structure cryoEM for pharma and biotech companies. From in silico design work to wet lab experimental validation, including protein production and structure determination.
Key technologies:
-
Protein design technology enabling several unique protein design strategies supporting antigen development (soluble analogues of membrane proteins, multi-epitope scaffolds, multimerizing scaffolds) and/or drug screening of membrane proteins
-
Unique portfolio of CryoEM grids addressing major bottlenecks in sample preparation (preferred particle orientation, protein complex disassembly) and related platform to study proteins isolated from patient-derived samples.
-
Portfolio of antigens from different bacterial and viral species.
Representatives
CEO
PUXANO